ATVB in focus novel approaches to the treatment of dyslipidemia

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 25, Issue 3, 2005, Pages 480-481

  Rader, Daniel J ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ANTILIPEMIC AGENT;

CARDIOVASCULAR RISK; CLINICAL TRIAL; DISEASE COURSE; DYSLIPIDEMIA; HUMAN; POPULATION DYNAMICS; PRIORITY JOURNAL; RISK ASSESSMENT; SHORT SURVEY; HYPERLIPIDEMIA; REVIEW;

ANTILIPEMIC AGENTS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERLIPIDEMIAS;

EID: 14644427215     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000154483.28595.a3     Document Type: Short Survey

References (0)